Poor prospects for share price13 Jul 2018 12:49
Unfortunately, I think the business plan for n4p is busted. Most people invested here for the drug reformulation idea, not for nuvec. I think the share price will follow the same path as imm. After imm's trial failed, there was a big drop followed by a small bounce over the next few days.Then the share price started to slide down steadily; I think the same thing will happen here.